Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases
NCT03135652Phase 2Withdrawn
- Start
- Aug 2017
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms). Primary endpoint: Disease free survival at 2 years. Planned start Aug 2017; status: withdrawn.
Beyond the preview
Go deeper on NCT03135652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03135652.